Skip to content

Bedal International

Active
Public limited companyfounded 2011active for 14 yearsAgoralaan Abis, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0841.685.826

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The annual accounts of Bedal International for financial year 2025 show a net loss of 66% of total assets. The 2025 annual accounts show equity of €3.5m and a net result of -€3.0m. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 71% of 239 sector peers (NACE 72, financial year 2025). The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Official details

KBO
Status
Active since 30-11-2011 Normal situation
Registered office
15 active companies are registered at this address Source: KBO register, as of 1 November 2026.
Activity
Other research and development on natural sciences NACE 72109and 1 other
Establishment unit
2.205.176.422 3590 Diepenbeek, since 15-12-2011
Financial year end
31 December
Peppol
Reachable since 06-05-2026

Board and ownership

Board
  • Maddoc Medical Products, Inc.Managing director · permanent representative Steve Bierman
  • BAM CONSULTDirector · since 04-07-2024 · permanent representative STAS Philippe
  • BAM CONSULTDirector · since 04-07-2024 · permanent representative STAS Philippe
  • DEVIANTDirector · since 04-07-2024 · permanent representative VAN DAMME Alexander
and 4 other directors
Holdings
Shares in 1 company Bedal Inc

Financial position

55 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts 2025
Gross margin
-€1.3m
▼ 3.0%
Loss
€3.0m
▼ 0.4%
Equity
€3.5m
▼ 45.6%
Total assets
€4.5m
▼ 35.1%
Staff
9 FTE
▲ 16.9%
Filed on 13-07-2026, 18 days before the deadlineat the National Bank
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €3.0m, the second in a row (financial year 2025)lowers riskFigures for financial year 2025 (filed on 13-07-2026)Equity €3.5m (78.2% of total assets)Legal form: public limited companyShow the evidence

Checked score

Score 2025
55 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 38% of micro companies in research and development (NACE 72)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Average
Solvency 100=
equity 78.2% of total assets
Liquidity 55-8
short-term debt 19.5% · cash 8.4%
Profitability 0=
return on assets -65.7%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: 2.4% 12-2024: 2.4%● unchanged vs 11-2024 01-2025: 2.4%● unchanged vs 12-2024 02-2025: 2.5%▲ +0.1 percentage points vs 01-2025 03-2025: 2.8%▲ +0.3 percentage points vs 02-2025 04-2025: 2.9%▲ +0.1 percentage points vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 3.1%▲ +0.2 percentage points vs 05-2025 07-2025: 3.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.4%▼ -2.8 percentage points vs 07-2025lowest value 09-2025: 0.4%● unchanged vs 08-2025lowest value 10-2025: 0.4%● unchanged vs 09-2025lowest value 11-2025: 0.4%● unchanged vs 10-2025lowest value 12-2025: 0.4%● unchanged vs 11-2025lowest value 01-2026: 0.4%● unchanged vs 12-2025lowest value 02-2026: 0.4%● unchanged vs 01-2026lowest value 03-2026: 0.4%● unchanged vs 02-2026lowest value 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.5%▲ +0.1 percentage points vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 0.6%▲ +0.1 percentage points vs 07-2026 09-2026: 0.6%● unchanged vs 08-2026 10-2026: 0.6%● unchanged vs 09-2026
Credit of up to €190,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity is ample, with a current ratio of 2.17 (14.21 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 8.4% of total assets. 21.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 41% on liquidity, 10% on profitability and 17% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Loss of €3.0m, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-07-2026)
NBB · annual accounts
lowers risk · Equity €3.5m (78.2% of total assets)
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€3.0m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 days early
2024
22 days early
2023
7 days early
2022
25 days late
2021
on the day
2020
9 days late
2019
69 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 8 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 8 loss-making years in a rowloss in financial year 2025 -€3.0m View
  • Caution: Lower net result than 86% of companies in research and developmentsector median €3,198 · 237 companies -€3.0m View
  • Caution: Equity fell in 2025from €6.5m to €3.5m ▼ 45.6% View
  • Flemish supportawarded from 2022 to 2025 €440,508 View
  • New directorlatest change 05-12-2025 · 7 in office 1 joined View

Companies linked to Bedal International

Comparable companies

These companies have the same main activity as Bedal International: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €3.1m and €12m, founded between 2002 and 2017.

CompanyTotal assetsGross margin
Bedal International Diepenbeek€4.5m-€1.3m
AARDEX Group Seraing€5.1m-€0.08m
Indigo Diabetes Gent€5.0m-€0.7m
ENDO TOOLS THERAPEUTICS Charleroi€5.1m-€2.2m
Hirundo Biosciences Liège€3.4m-€2.9m
FYTEKO Anderlecht€11.7m-€0.04m
reMYND Leuven€3.1m-€0.2m
Full comparison

Documents

Annual accounts at the NBB

All 14 annual accounts

Articles and registers

Key facts about Bedal International

What is the company number of Bedal International?
The company number of Bedal International is 0841.685.826. The VAT number is the same number with BE in front: BE 0841.685.826.
Where is Bedal International based?
The registered office is at Agoralaan Abis, 3590 Diepenbeek.Company details
What does Bedal International do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of Bedal International?
The legal form of Bedal International is Public limited company (NV).
When was Bedal International founded?
Bedal International was founded on 30-11-2011.
Is Bedal International still active?
Yes, Bedal International is an active enterprise in the KBO register.
How many employees does Bedal International have?
Bedal International had an average of 9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Bedal International?
The annual accounts for financial year 2025 state no turnover.
Is Bedal International profitable?
In financial year 2025, Bedal International made a loss of €3.0m.
Where can I find the annual accounts of Bedal International?
Bedal International filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Bedal International due?
Bedal International must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.